NASDAQ:FBRX

Forte Biosciences Stock Insider Trading

Healthcare > Biotechnology

Buy FBRX

*Your capital is at risk

$44.12

+0.200 (+0.455%)

At Close: Jul 13, 2026

Forte Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.83. In total, the insiders bought 4.24M and sold 2.69K FBRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.83
● Buy	4.24M shares
● Sell	2.69K shares
78% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jul 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.83. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Wagner Paul A. See Remarks	Officer	1 250 Value: $26.7K
Jul 01, 2026 Sell	Common Stock F-InKind	Wagner Paul A. See Remarks	Officer	98 Value: $2K
Jul 01, 2026 Buy	Common Stock M-Exempt	Wagner Paul A. See Remarks	Officer	1 250 Value: $26.7K
Jul 01, 2026 Buy	Restricted Stock Units M-Exempt	Riley Antony A Chief Financial Officer	C-Suite Officer	375 Value: $8K
Jul 01, 2026 Buy	Common Stock M-Exempt	Riley Antony A Chief Financial Officer	C-Suite Officer	375 Value: $8K
Jul 01, 2026 Sell	Common Stock F-InKind	Riley Antony A Chief Financial Officer	C-Suite Officer	134 Value: $3K
Jun 16, 2026 Buy	Stock Option (right to buy) A-Award	Riley Antony A Chief Financial Officer	C-Suite Officer	22 000 Value: $377.3K
Jun 16, 2026 Buy	Stock Option (right to buy) A-Award	Wagner Paul A. See Remarks	Officer	500 000 Value: $8.58M
May 29, 2026 Buy	Restricted Stock Units A-Award	Gryska David W Director	Director	18 353 Value: $350.0K
May 29, 2026 Buy	Restricted Stock Units A-Award	Vincent Richard G Director	Director	18 353 Value: $350.0K
May 29, 2026 Buy	Restricted Stock Units A-Award	Kapoor Shivpreet Singh Director	Director	18 353 Value: $350.0K
May 29, 2026 Buy	Restricted Stock Units A-Award	Doberstein Stephen K Director	Director	18 353 Value: $350.0K
May 29, 2026 Buy	Restricted Stock Units A-Award	Brun Scott C. Director	Director	18 353 Value: $350.0K
May 29, 2026 Buy	Restricted Stock Units A-Award	Kornfeld Steven Director	Director	18 353 Value: $350.0K
Apr 01, 2026 Sell	Common Stock F-InKind	Riley Antony A Chief Financial Officer	C-Suite Officer	134 Value: $3K
Apr 01, 2026 Buy	Common Stock M-Exempt	Riley Antony A Chief Financial Officer	C-Suite Officer	375 Value: $9K
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Riley Antony A Chief Financial Officer	C-Suite Officer	375 Value: $9K
Apr 01, 2026 Buy	Common Stock M-Exempt	Wagner Paul A. See Remarks	Officer	1 250 Value: $31.1K
Apr 01, 2026 Sell	Common Stock F-InKind	Wagner Paul A. See Remarks	Officer	98 Value: $2K
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Wagner Paul A. See Remarks	Officer	1 250 Value: $31.1K
Jan 12, 2026 Buy	Restricted Stock Units A-Award	Wagner Paul A. See Remarks	Officer	180 000 Value: $5.34M
Jan 12, 2026 Buy	Stock Option (right to buy) A-Award	Wagner Paul A. See Remarks	Officer	270 000 Value: $8.01M
Jan 12, 2026 Buy	Restricted Stock Units A-Award	Riley Antony A Chief Financial Officer	C-Suite Officer	60 000 Value: $1.78M
Jan 12, 2026 Buy	Stock Option (right to buy) A-Award	Riley Antony A Chief Financial Officer	C-Suite Officer	90 000 Value: $2.67M
Jan 01, 2026 Buy	Common Stock M-Exempt	Riley Antony A Chief Financial Officer	C-Suite Officer	375 Value: $16.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT FORTE BIOSCIENCES INC.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas....

Read Full Profile Here